Literature DB >> 6245985

Liver collagenase in murine schistosomiasis.

S Takahashi, M A Dunn, S Seifter.   

Abstract

Mice infected with Schistosoma mansoni represent a model for study of the most prevalent form of hepatic fibrosis in humans. In the present study, collagenase activity was measured in relation to collagen synthesis and accumulation in the livers of mice 6-11 wk after after infection. Total and latent collagenase and elastase activities and collagen synthesis were maximal 8 wk after infection and decreased thereafter, whereas collagen content progressively increased to the 11th wk. Maximal enzymatic activity coincided with the known peak of host cellular immune responses. Collagenase and elastase activities were isolated from liver homogenates. Isolated schistosome eggs did not contain collagenase or elastase activities. Collagenolytic activity had the characteristics of a tissue collagenase. These data show that marked increases in collagenase activity occur together with increased collagen synthesis in this animal model. Continued accumulation of liver collagen under these conditions suggests an imbalance between increased collagen synthesis and degradation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245985

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  16 in total

Review 1.  Is liver fibrosis reversible?

Authors:  R C Benyon; J P Iredale
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

2.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat.

Authors:  G Abdel-Aziz; G Lebeau; P Y Rescan; B Clément; M Rissel; Y Deugnier; J P Campion; A Guillouzo
Journal:  Am J Pathol       Date:  1990-12       Impact factor: 4.307

3.  Detection of alpha 2-macroglobulin, alpha 1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of Schistosoma mansoni-infected mice.

Authors:  J L Truden; D L Boros
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 4.  Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies.

Authors:  Rashad A Abdul-Ghani; Azza A Hassan
Journal:  Parasitol Res       Date:  2010-04-06       Impact factor: 2.289

5.  Evolution of the schistosomal hepatic lesions in mice after curative chemotherapy.

Authors:  Z A Andrade; J A Grimaud
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

6.  Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice.

Authors:  Ekhlas H Abdel-Hafeez; Azza K Ahmad; Ahlam M Abdulla; Soha Aabdel-Wahab; Fadia A Mosalem
Journal:  Parasitol Res       Date:  2012-03-08       Impact factor: 2.289

7.  Radioimmunoassay of soluble and insoluble collagenases in fibrotic liver.

Authors:  S Takahashi; K Koda
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

8.  Identification of cytokeratin 18 as a biomarker of mouse and human hepatosplenic schistosomiasis.

Authors:  Bhagyashree Manivannan; Pisana Rawson; T William Jordan; Diana M S Karanja; Pauline N M Mwinzi; William Evan Secor; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

9.  Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Dov L Boros
Journal:  Immunology       Date:  2004-03       Impact factor: 7.397

10.  Collagen metabolism in fibrotic liver. Effects of concanavalin A and aggregated myeloma immunoglobin G.

Authors:  S Takahashi; M J Lee
Journal:  Biochem J       Date:  1987-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.